RSS Feeds
Search

Industry news

News of the day

CULS Conversion and Additional Listing

1 September 2010--Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that it has received conversion requests in respect of more

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

Malvern, PA, [September 1, 2010] - Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy more

Ferro Corporation Announces Expiration and Final Results of Tender Offer for its 6.50% Convertible Senior Notes Due 2013

CLEVELAND, August 31, 2010 --Ferro Corporation (NYSE: FOE), announced today the final results of its tender offer for all of its outstanding 6.50% Convertible Senior Notes due 2013 (the "Convertible Notes"), which expired at midnight, New York City time, on August 30, 2010 (the "Expiration Time"). Ferro has purchased all of the $100,504,000 in aggregate principal amount of Convertible Notes, or approximately 58% of the outstanding Convertible Notes, that were validly tendered and not validly... more

Industry news search

Search the Pharmalicensing Industry news by keyword. Alternatively our advanced search allows you to query by category and therapeutic target.
 
Category Therapeutic target
 
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Recent news

To keep up to date with news from this category use our RSS Feed to keep up to date

PharmaGap Announces Closing of First Tranche of Private Placement
Ottawa, Ontario/ August 30, 2010 - PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") announced today that it has completed the initial tranche of an offering of equity units (the "Units")...

THERMOGENESIS ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE ON NASDAQ CAPITAL MARKET AUGUST 27, 2010
(RANCHO CORDOVA, CA), August 26, 2010--ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said it has filed a Certificate of Amendment...

Achillion Announces Private Placement of $50 Million
NEW HAVEN, Conn., Aug. 18, 2010 -- Achillion Pharmaceuticals, Inc., (Nasdaq:ACHN) a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced...

THERMOGENESIS ANNOUNCES STOCKHOLDER AUTHORIZATION OF REVERSE SPLIT
(RANCHO CORDOVA, CA), August 11, 2010--ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that its Board of Directors has...

TetraLogic Pharmaceuticals COMPLETES $32 Million SERIES C FINANCING
Malvern, PA, August 10, 2010 - TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new...

PRO-DEX, INC. ANNOUNCES REVERSE STOCK SPLIT TO BE EFFECTIVE JUNE 18,2010
lRVINE, CA, June 01, 20 I 0 - PRO-DEX, INC. (NASDAQ: PDEX) today announced that its Board of Directors has detennined to effect a reverse split of the Company's common stock pursuant to authority previously granted...

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us